Population pharmacokinetics and exposure‐response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis

Population pharmacokinetics and exposure‐response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis

Abstract Upadacitinib is an orally administered, selective, Janus kinase inhibitor that is approved for several auto‐immune conditions, such as axial spondyloarthritis, an inflammatory rheumatic disease that includes ankylosing spondylitis (AS) and non‐radiographic axial spondyloarthritis (nr‐axSpA)...

Full description

Bibliographic Details
Main Authors:	Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In‐Ho Song, Peter Wung, Wei Liu, Mohamed‐Eslam F. Mohamed
Format:	Article
Language:	English
Published:	Wiley 2024-02-01
Series:	Clinical and Translational Science
Online Access:	https://doi.org/10.1111/cts.13733

Similar Items

Management of Axial Spondyloarthritis – Insights into Upadacitinib
by: Braun J, et al.
Published: (2022-10-01)

Upadacitinib: Mechanism of action, clinical, and translational science
by: Mohamed‐Eslam F. Mohamed, et al.
Published: (2024-01-01)

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis
by: Andrea Rubbert-Roth, et al.
Published: (2023-11-01)

Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2
by: Uta Kiltz, et al.
Published: (2023-05-01)

The use of tenoxicam in active axial spondyloarthritis – focus on efficacy and safety
by: A. P. Rebrov, et al.
Published: (2022-12-01)

Etanercept in axial spondyloarthritis
by: Gui Luo, et al.
Published: (2022-11-01)

«FLARES» IN AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-07-01)

Progression of axial spondyloarthritis
by: Sh. F. Erdes, et al.
Published: (2021-06-01)

Etanercept in axial spondyloarthritis – treatment efficacy
by: I. Z. Gaydukova, et al.
Published: (2022-03-01)

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
by: Xenofon Baraliakos, et al.
Published: (2023-04-01)

Uncovering the Underworld of Axial Spondyloarthritis
by: Sergio Del Vescovo, et al.
Published: (2023-03-01)

Coxitis in early axial spondyloarthritis
by: E. M. Agafonova, et al.
Published: (2019-10-01)

Axial Spondyloarthritis: An Evolving Concept
by: Nelly Ziadé
Published: (2015-07-01)

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
by: Baraliakos, X, et al.
Published: (2023)

Korean treatment recommendations for patients with axial spondyloarthritis
by: Mi Ryoung Seo, et al.
Published: (2023-09-01)

Novel therapeutic targets in axial spondyloarthritis
by: Worth, C, et al.
Published: (2018)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-02-01)

Editorial: Radiographic progression in axial spondyloarthritis
by: F. M. Pimentel-Santos, et al.
Published: (2023-06-01)

Korean treatment recommendations for patients with axial spondyloarthritis
by: Mi Ryoung Seo, et al.
Published: (2024-01-01)

Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST
by: Maxime Dougados, et al.
Published: (2022-12-01)

MRI Workshop for Axial Spondyloarthritis 2023 Interpretation of MRI Spine
by: Ho Yin CHUNG
Published: (2023-11-01)

Diet and Disease Activity in Patients with Axial Spondyloarthritis: SpondyloArthritis and NUTrition Study (SANUT)
by: Pascale Vergne-Salle, et al.
Published: (2022-11-01)

Entry point of machine learning in axial spondyloarthritis
by: Tiantian Sun, et al.
Published: (2024-02-01)

The Taiwanese Map of Axial Spondyloarthritis: Living with the Condition
by: Yi-Ning Yen, et al.
Published: (2023-11-01)

Searching for New Genetic Biomarkers of Axial Spondyloarthritis
by: Bartosz Bugaj, et al.
Published: (2022-05-01)

ASSESSMENT OF COXITIS PROGRESSION IN EARLY AXIAL SPONDYLOARTHRITIS
by: E. M. Agafonova, et al.
Published: (2020-04-01)

UPDATED ASAS-EULAR GUIDELINES FOR AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-12-01)

Anxiety and depression among patients with axial spondyloarthritis
by: Kamini Narendra Reddy, et al.
Published: (2022-01-01)

Is neuropathic pain an overlooked symptom in axial spondyloarthritis?
by: Esra Kayacan Erdoğan, et al.
Published: (2022-09-01)

Original paper Cytokine profiles in axial spondyloarthritis
by: Marta Madej, et al.
Published: (2015-04-01)

Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
by: Yuankai Sun, et al.
Published: (2022-11-01)

USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS, MONITORING THEIR EFFICACY AND SAFETY (DRAFT GUIDELINES OF THE EXPERT SPONDYLOARTHRITIS DIAGNOSIS AND TREATMENT GROUP)
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)

Pain in axial spondyloarthritis: role of the JAK/STAT pathway
by: Carlo Selmi, et al.
Published: (2024-02-01)

Psoriasis seems often underdiagnosed in patient with axial spondyloarthritis
by: Angelique Rondags, et al.
Published: (2023-08-01)

Diagnostic value of anti-Kaiso autoantibody in axial spondyloarthritis
by: Xinzhe Feng, et al.
Published: (2023-03-01)

Clinical evaluation of foot disability in patients with axial spondyloarthritis
by: Lale Altan
Published: (2020-11-01)

Bone mineral density in patients with early axial spondyloarthritis
by: E. E. Gubar, et al.
Published: (2015-03-01)

Prevalence of pistol-grip deformity in patients with axial spondyloarthritis
by: Özgür Tosun, et al.
Published: (2021-07-01)

Mucosal-associated invariant T cells in patients with axial spondyloarthritis
by: Rienk Gerben van der Meer, et al.
Published: (2023-03-01)

The Italian Society for Rheumatology recommendations for the management of axial spondyloarthritis
by: M. Manara, et al.
Published: (2021-08-01)